2024 ICD-10-CM Diagnosis Code C39

by

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

  • C39 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • Short description: Malig neoplm of sites in the resp sys and intrathorac organs
  • The 2024 edition of ICD-10-CM C39 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C39 – other international versions of ICD-10 C39 may differ.

Use Additional

  • code to identify:
  • exposure to environmental tobacco smoke (Z77.22)
  • exposure to tobacco smoke in the perinatal period (P96.81)
  • history of tobacco dependence (Z87.891)
  • occupational exposure to environmental tobacco smoke (Z57.31)
  • tobacco dependence (F17.-)
  • tobacco use (Z72.0)

Type 1 Excludes

  • intrathoracic malignant neoplasm NOS (C76.1)
  • thoracic malignant neoplasm NOS (C76.1)

The following code(s) above C39 contain annotation back-references

 that may be applicable to C39:

  • C00-D49  Neoplasms
  • C30-C39  Malignant neoplasms of respiratory and intrathoracic organs

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change
error: Content is protected !!